The Conference call scheduled last Monday April 27, 2020 at 6:00 pm (CET) presented Adocia results and provided a business update at the occasion of Adocia Press Release announcing positive topline results of the exploratory Phase 1b study of ADO09 (M1Pram) in people with type 1 diabetes.
Gérard Soula, Adocia CEO
Valérie Danaguezian, Financial Director
Olivier Soula, Deputy General Manager – R&D Director
Please, see attached the transcript of the call attached.
A replay number is made available to you for 90 days after the conference call:
France : +33 (0)1 72 72 74 02 AND Access code: 418929850#